US Patent 11273215 Synthetic polypeptide epitope based vaccine composition

Patent 11273215 was granted and assigned to Bharat Biotech on March, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Bharat Biotech

Current Assignee

Bharat Biotech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

112732150

Patent Inventor Names

Amit Raychoudhuri0

Date of Patent

March 15, 2022

Patent Application Number

166280570

Date Filed

July 3, 2018

Patent Primary Examiner

‌

Stacy B. Chen

Conserved epitopes selected from EV71 and CVA16, the two major causative agents of Hand Foot and Mouth Disease has been used to develop sub-unit bivalent vaccine antigen construct. The said vaccine described in this invention is capable to provide cross-protection to diverse EV71 and CVA16 infection causing strains. Further disclosed are the expression of the multi-epitope vaccine antigen coding gene and the purification process involved thereof. This present invention also discloses vaccine formulations against Hand Foot and Mouth Disease and other enterovirus infections comprising the recombinant vaccine antigen construct of the present invention.